Excess vascular oxidative stress and the local formation of oxidized LDL (ox-LDL) have been implicated in the development of impaired endothelium-dependent arterial relaxation in hypercholesterolemia and atherosclerosis. Dietary antioxidants limit LDL oxidation in vitro and treatment of cholesterol-fed rabbits with dietary antioxidants preserves endothelium-derived relaxing factor (EDRF) The vascular endothelium is important in the maintenance of vascular homeostasis. Normally, the vascular endothelium prevents inappropriate vasospasm and platelet adhesion to the vascular surface through the production of numerous paracrine factors (for review see reference 1). Principal among these mediators of vascular homeostasis is endothelium-derived relaxing factor (EDRF),' an endothelial product that has been identified as nitric oxide (NO) (2), or a closely related redoxactivated form of NO (3) . This endothelial product relaxes vascular smooth muscle and prevents platelet adhesion to the endothelial surface through a cyclic 3 ',5 '-guanosine monophosphate-mediated mechanism (4, 5). Abnormalities in EDRF action have been described in association with known risk factors for acute vascular events including hypercholesterolemia (6) and atherosclerosis (7). These abnormalities develop early in the course of vascular disease (6, 8) and may participate in the development of clinically significant vascular events.
The vascular endothelium is important in the maintenance of vascular homeostasis. Normally, the vascular endothelium prevents inappropriate vasospasm and platelet adhesion to the vascular surface through the production of numerous paracrine factors (for review see reference 1). Principal among these mediators of vascular homeostasis is endothelium-derived relaxing factor (EDRF),' an endothelial product that has been identified as nitric oxide (NO) (2) , or a closely related redoxactivated form of NO (3) . This endothelial product relaxes vascular smooth muscle and prevents platelet adhesion to the endothelial surface through a cyclic 3 ',5 '-guanosine monophosphate-mediated mechanism (4, 5) . Abnormalities in EDRF action have been described in association with known risk factors for acute vascular events including hypercholesterolemia (6) and atherosclerosis (7) . These abnormalities develop early in the course of vascular disease (6, 8) and may participate in the development of clinically significant vascular events.
There are now several lines of evidence linking excess vascular oxidative stress to the impairment of EDRF action associated with hypercholesterolemia and atherosclerosis. Early in atherogenesis, LDL becomes entrapped in the subendothelial space of lesion-prone arterial sites where it is subject to oxidation by endothelial cells (9) , smooth muscle cells (10) , and resident monocyte/macrophages (11) . Oxidized LDL (ox-LDL) inhibits receptor-mediated endothelium-dependent arterial relaxation (12) and signal transduction (13) . Moreover, ox-LDL is cytotoxic (14) and degrades EDRF directly (15) , further promoting abnormal EDRF action.
Other sources of vascular oxidative stress may also contribute to impaired EDRF action. EDRF is readily inactivated by superoxide (16) and the action of EDRF is dependent upon intact endothelial SOD activity (17) . In particular, arteries derived from cholesterol-fed rabbits produce excess superoxide (18) and the administration of SOD to atherosclerotic rabbits improves EDRF action (19, 20) . Thus, there is considerable evidence indicating that excess vascular oxidative stress contributes to impaired EDRF action in experimental hypercholesterolemia and atherosclerosis.
Developing evidence also suggests that improved vascular antioxidant defenses may limit abnormalities of endotheliumdependent arterial relaxation associated with hypercholesterolemia and atherosclerosis. Atherosclerotic rabbits treated chronically with probucol, a cholesterol-lowering drug with potent antioxidant properties (21) , exhibit preserved endothelium-de-pendent arterial relaxation compared to animals fed cholesterol alone (22) . Similarly, cholesterol-fed rabbits treated with other lipid-soluble antioxidants such as a-tocopherol (23, 24) and /3-carotene (23) demonstrate preserved EDRF action in association with incorporation of these agents into vascular tissue (23) . Similar findings have been reported with cholesterol-fed rats, animals that do not typically demonstrate impaired endothelium-dependent arterial relaxation unless they are simultaneously deficient in selenium and a-tocopherol (25) . Despite the demonstration that some antioxidants preserve endothelium-dependent arterial relaxation in hypercholesterolemia and atherosclerosis, the precise mechanism(s) that underlie this phenomenon are not well defined. Thus, we sought to examine the mechanism(s) by which enhanced vascular antioxidant protection preserves endothelium-dependent arterial relaxation in the cholesterol-fed rabbit model using probucol.
Methods
Materials. Ketamine hydrochloride was purchased from Aveco Co., Inc 7.4 . Reagents used for LDL experiments were prepared with Chelex-treated, double-distilled, deionized water to prevent premature LDL oxidation catalyzed by trace amounts of transition metal ions. A23 187 was prepared and diluted in 2% DMSO while all other reagents were prepared with distilled water.
Animal subjects. 64 male New Zealand White rabbits (2.6-3.8 kg) were exposed to dietary treatment for a period of 28 d. 16 of these animals were fed standard rabbit chow and served as the control group. 48 animals were fed a chow diet containing the following supplements (n = 16 per group): (a) 0.5% (wt/wt) cholesterol, (b) 1% (wt/wt) cholesterol; and (c) 1% cholesterol with 1% (wt/wt) probucol. Cholesterol chow was prepared by dissolving pure cholesterol (Sigma Chemical Co.) in ether and spraying the appropriate amount over standard chow. Animals consumed chow and water ad libitum. Blood was obtained in Vacutainer tubes (4.5 mg Na2EDTA/3 ml) before dietary treatment and at the time of death. Plasma was prepared and stored at -70°C for subsequent assay of plasma cholesterol, triglyceride, and antioxidant levels. Plasma total cholesterol (26) and triglycerides (27) were quantified using enzymatic methods.
In vitro assay of vascularfunction. Rabbits were killed with pentobarbital ( 120 mg/kg) via a marginal ear vein, the thoracic aorta excised, and vessel segments suspended in organ chambers as previously described (23) . Endothelial control of vascular tone was assayed by the addition of the muscarinic agonist acetylcholine (final concentration 10-9-10-5 M) and the calcium ionophore A23187 (10-95_10-6 M), while smooth muscle cell vasodilator function was assayed using sodium nitroprusside (10-9-10-5 M).
Plasma, LDL, and aortic antioxidant content. Plasma and aortic probucol content was determined by the method of Mao and colleagues (28) using HPLC with a 25-cm LC-18 column (Supelco Inc., Bellfonte, PA) and ultraviolet detection ( 1050 series chemstation; Hewlett-Packard Co., Palo Alto, CA). Plasma a-tocopherol content was determined as described (29) after saponification for 30 min with 10 N KOH in the presence of 25% ascorbate. For aortic a-tocopherol content, tissue samples (0.1-0.35 g) were prepared as described (23) and subjected to reverse-phase HPLC (29) using an amperometric electrochemical detector (model 1049A; Hewlett-Packard Co.) at an applied potential of 0.6 V. Calibration of the HPLC system was performed daily using fresh solutions of d,1-a-tocopherol in ethanol. For LDL antioxidant content, a 125-kul sample containing 0.1 mg LDL protein in PBS was extracted with 125 kl methanol and 2.5 ml hexane. The hexane phase (2.0 ml) was dried under nitrogen, resuspended in ethanol, and subjected to reverse-phase HPLC with electrochemical detection as described above except that the applied potential was 1.0 V. Calibration of the HPLC system was performed daily using fresh solutions of d,1-a-tocopherol and probucol in ethanol.
LDL oxidation studies. The isolation and oxidation of LDL were performed as described previously (30 [33] ) for 30 min in oxygenated PSS before transfer to scintillation vials containing 2 ml of Hepes-buffered PSS (PSS containing 20 mM Hepes), with 0.25 mM lucigenin (bis-Nmethylacridium nitrate). After 10 min of dark adaptation, superoxide generation was estimated as described previously using the chemiluminescence signal from a scintillation counter (model LKB; Wallac Ltd., Gaithersburg, MD) in out of coincidence mode ( 18, 34, 35) . Chemiluminescence values were obtained at 1-min intervals over 10 min and the readings in each of the last 5 min averaged. Background counts were determined from identically processed vessel-free incubations and subtracted from the readings obtained with vessels. Chemiluminescence was inhibited > 95% by pretreatment of arterial segments with 10 mM Tiron (4,5 dihydroxy-1,3-benzene sulfonic acid salt), a known scavenger of superoxide anions (36) .
Vascular superoxide scavenging activity. Vascular superoxide scavenging activity was determined using the method of Salin and McCord (37) with some modification. Segments of thoracic aorta (-50 mg) were harvested as described above and homogenized in PBS (2 ml) using a homogenizer (Brinkmann Instruments, Inc., Westbury, NY). For the assessment of water-soluble superoxide scavenging activity, the homogenates were centrifuged at 13,600 g for 15 min-and the supernatant collected and stored on ice until analysis. Water-soluble superoxide scavenging activity was assayed using a xanthine/xanthine oxidase superoxide generating system and the SOD-inhibitable reduction of cytochrome c as follows: The water soluble homogenate (0.1 ml) was incubated with 100 MM xanthine, 15 MM cytochrome c (horse heart type (38) . In this assay, o-dianisidine is photooxidized in the presence of riboflavin leading to the formation of a stable product (oxidized dianisidine) that absorbs at 460 nm. Superoxide is also produced in this assay and reduces partially oxidized dianisidine leading to a net decrease in the accumulation of 460-nm product. Thus, compounds that preferentially scavenge superoxide (such as SOD) lead to an increase in 460 nm absorbance in this assay. In contrast, general free radical scavengers or agents without activity will either decrease 460 nm absorbance or have no effect, respectively (38) . Authentic probucol (1.9-18.5 nmol/ml) was used as a positive control. Pathologic examination. The thoracic aorta was perfusion fixed and representative histologic sections of the proximal, mid, and distal thoracic aorta were prepared as described (23) . Sections were stained with resorcin fuchsin (for elastin) and subjected to morphometric analysis of intimal and medial area using microscope (model BH-2; Olympus Corp., Lake Success, NY) and an automated videomicroscopy system (Optimas, BioScan Inc., Edmonds, WA).
Tissue cholesterol and lysophosphatidylcholine content. Segments of thoracic aorta not used for superoxide assay were homogenized in the presence of 50 ,M butylated hydroxytoluene and 0.1 mM diethylenetriaminepentaacetic acid and total lipids extracted with chloroform/ methanol as above. For the determination of cholesterol content, an aliquot (0.1 ml) of lipid extract was dried under nitrogen and resuspended in absolute ethanol. The total cholesterol content (free cholesterol + cholesterol ester) of this lipid suspension was determined using enzymatic methods (26) with a commercially available kit (Sclavo, Inc., Wayne, NJ). The remaining lipid extract was assayed for phosphatidylcholine (PC) and lysophosphatidylcholine (lysoPC) content using the method of Kaduce and colleagues (39 (Table I ). All four treatment groups gained weight to a similar degree over the study period with no significant differences on the basis of dietary treatment (Table I) . All values represent mean±SEM of samples taken from seven to nine animals in each group. * P < 0.001 compared to control group. n.d., not detected.
(83±5%) that was not significantly different from control rabbits. There was no significant relaxation to acetylcholine in vessels without endothelium (data not shown). Vessel relaxations to the receptor-independent EDRF agonist, A23187 are presented in Fig. 1 B. Vessels harvested from control rabbits demonstrated significant dose-dependent relaxation in response to A23187 with a maximal response of 95±6% (P < 0.001). Relaxation in vessels from the 0.5% cholesterol group was similar to the control group with a maximal relaxation of 95_±5%, whereas vessels derived from the 1% cholesterol group demonstrated a modest impairment in the response to A23187 compared to control vessels (81±5%, P < 0.05). In vessels derived from probucol-treated animals, the response to A23187 was not significantly different than control vessels with a maximal relaxation of 95±2% (Fig. 1 B) . In vessels without endothelium, there was no significant relaxation to A23187.
The vasodilator response to the NO donor, sodium nitroprusside was similar in the four treatment groups and these results are presented in Fig. 1 C. Vessels in all four groups demonstrated dose-dependent vasodilatation in response to increasing concentrations of sodium nitroprusside (P < 0.001) with no significant differences noted on the basis of dietary treatment or the presence of endothelium.
LDL oxidation studies. Hypercholesterolemia and atherosclerosis are accompanied by the local vascular accumulation of ox-LDL (40) that has been shown to inactivate EDRF directly (15) . To determine whether LDL probucol may influence the vascular formation of ox-LDL we assayed plasma-derived LDL in the four treatment groups for resistance to copperinduced oxidation as well as a-tocopherol and probucol content (Table II) . LDL isolated from rabbits fed chow, 0.5% cholesterol, or 1% cholesterol alone demonstrated similar resistance to copper-induced oxidation with lag phase times of 96±7, 87±7, and 98±5 min, respectively (P = NS). In contrast, LDL isolated from animals fed 1% cholesterol and 1% probucol was markedly resistant to ex vivo copper-induced oxidation as evidenced by a lag phase of 224±12 min (P < 0.001 vs control). LDL antioxidant content paralleled the dietary treatment (Table  II) . LDL derived from all four treatment groups demonstrated similar a-tocopherol content. As expected, probucol was detected only in LDL derived from probucol-fed animals at a level of 14.5±3.3 nmol/mg LDL protein (Table H) .
Vascular accumulation of TBARS. We next sought to determine if the effect of probucol on LDL resistance to oxidative modification was reflected in a reduction of vascular oxidation 2.5- products. Therefore, we determined the level of TBARS in segments of thoracic aorta from animals used in this study and these results are presented in Fig. 2 Endothelium-dependent arterial relaxation and indices of antioxidant protection. To investigate whether vascular oxidative stress is associated with impaired vascular reactivity, we examined the relationship between the antioxidant effects of probucol and endothelium-dependent arterial relaxation. We found a strong association between indices of antioxidant protection and preservation of endothelial function (Fig. 3) . LDL resistance to ex vivo copper-induced oxidation correlated with receptor-mediated endothelium-dependent arterial relaxation to acetylcholine (r = 0.59, P = 0.0007; Fig. 3 A) . In addition, arterial relaxation to acetylcholine also correlated with vascular TBARS (r = -.54, P = 0.008; Fig. 3 B) , an indirect indicator of vascular oxidative stress. In contrast, we did not see any significant association between relaxation to A23187 and LDL lag phase (r = 0.07; P = 0.77) or vascular TBARS (r = 0.17; P = 0.41).
Estimation of vascular superoxide generation. The precise source(s) of vascular oxidative stress and the mechanism(s) of ox-LDL formation in vivo are unknown. However, several investigators have implicated cellular superoxide generation as a critical event for both cellular LDL modification (41) (42) (43) and inactivation of EDRF (16, 17) . We sought to determine if the beneficial effects of probucol on vascular oxidative stress and EDRF action may be a consequence of reduced vascular superoxide generation. Vascular superoxide generation from the thoracic aorta of all four treatment groups was estimated using lucigenin chemiluminescence (18, 34, 35) the CuZnSOD inhibitor, DDC. As shown in Fig. 4 , vessels derived from control rabbits demonstrated a signal of 5,668±707 cpm/mg tissue, whereas vessels from the 0.5 and 1% cholesterol groups exhibited chemiluminescence signals that were 1.5-and 2.1-fold greater than control (8,763±405 and 12,002±822 cpm/mg, respectively; P < 0.05 vs control). In marked contrast, vessels derived from animals fed 1% cholesterol and 1% probucol demonstrated chemiluminescence signals comparable with control animals (4,368±386 cpm/mg). Thus, dietary probucol prevented the increase in vascular superoxide generation that was associated with cholesterol feeding.
Vascular superoxide scavenging activity and antioxidant content. The net vascular production of superoxide is a function of both superoxide generation and local superoxide scavenging. Arterial tissue contains considerable amounts of SOD that effectively converts superoxide to H202 and oxygen. In the above experiments (Fig. 4) , we assessed vascular superoxide generation in the presence of DDC, an inhibitor of CuZnSOD, a major source of superoxide catabolism in arterial tissue (44) . There are, however, other potential sources of superoxide scavenging in arterial tissue including MnSOD (45), ascorbate, and atocopherol (46). In addition, there is at least one report indicating that probucol scavenges superoxide in vitro (47) . Therefore, we sought to determine if probucol treatment was associated with any differences in CuZnSOD activity or water-and lipidsoluble superoxide scavenging activity in the thoracic aorta of our study animals and these results are shown in Table III .
As shown in Table HI ( Table III ). The tissue content of lipid-soluble antioxidants is also contained in Table Ill and demonstrates that the arterial content of a-tocopherol was not significantly different among dietary groups. As expected, probucol was detected only in the aorta of animals consuming 1% cholesterol and 1% probucol (Table III) . Thus, the addition of probucol to a cholesterol diet reduced vascular superoxide generation, but did not increase vascular superoxide scavenging activity. Pathologic examination of vascular tissue and vascular tissue composition. Previous studies have linked endothelial dysfunction to the extent of atherosclerosis in animal models (48, 49) and probucol inhibits atherogenesis in some experimental models (50, 51) . The effects of dietary intervention on atherogenesis was assessed by evaluating the extent of intimal proliferation in segments of thoracic aorta (Table IV) . Using the ratio of intimal area to medial area as an index of intimal proliferation, aortas derived from the 0.5 and 1% cholesterol groups demonstrated intimal to medial ratios of 4.36±1.80 X 10' and 9.74±2.40 X 10-3, respectively (P < 0.05 vs control for 1% cholesterol group only). The intimal to medial ratio in the probucol group 8.26±1.74 X 10-3 was not significantly different from the other cholesterol-fed groups (P = 0.23). In contrast, vessels derived from control animals exhibited no significant intimal proliferation with an intimal to medial ratio of 0.56±0.45 x 10-3.
As shown in Fig. 4 and reported previously ( 18) , hypercholesterolemia in rabbits is associated with excess net vascular superoxide production, and dietary treatment of hypercholesterolemia corrects this abnormality (52). Probucol is known to limit atherogenesis and the vascular accumulation of cholesterol in animal models (53) . Therefore, we examined whether the decreased rate of superoxide generation in probucol-fed animals could be explained by decreased vascular cholesterol content. As shown in Table IV (34) . LDL oxidation is associated with intraparticle conversion of PC to lysoPC (54) , and probucol has been shown to limit LDL oxidation (21 ) and the vascular accumulation of ox-LDL in experimental atherosclerosis (51) . In thoracic aortas derived from animals consuming 0.5 and 1% cholesterol the lysoPC content was significantly elevated compared to chow-fed animals (both P < 0.05 vs chow-fed animals). In animals consuming 1% cholesterol with 1% probucol, the lysoPC content of thoracic aorta was not significantly different from chow-fed animals (Table  IV) . With respect to the aortic content of PC, this parameter was reduced only in the animals fed 1% cholesterol alone (Table  IV) . We also found a significant reduction in the ratio of PC to lysoPC, an index of phospholipid oxidation, in animals fed 0.5 or 1% cholesterol alone. In contrast, animals fed 1% cholesterol with 1% probucol did not demonstrate a significant reduction in the ratio of PC to lysoPC (Table IV) . Thus, the addition of probucol to a 1% cholesterol diet was associated with a significant reduction in vascular phospholipid oxidation and the vascular content of lysoPC.
To substantiate a role for lysoPC in vascular superoxide generation, we examined the relationship between the vascular chemiluminescence signal in the presence of DDC and phospholipid oxidation (Fig. 5) . We found that vascular superoxide generation positively correlated with the vascular content of lysoPC (r = 0.75, P = 0.001; Fig. 5 A) , and inversely correlated with the ratio of PC to lysoPC in the thoracic aorta (r = -0.67; P = 0.006; Fig. 5 B) . In contrast, there was no significant correlation between vascular cholesterol content and superoxide generation (r = 0.25; P = 0.36).
Discussion
The data presented here demonstrate that probucol, a lipidsoluble antioxidant, prevents the development of endothelial vasodilator dysfunction in cholesterol-fed rabbits. The prevention of endothelial dysfunction was not a consequence of probucol-mediated effects on plasma cholesterol, intimal proliferation, or any alteration in smooth muscle sensitivity to sodium probucol for a period of 28 d. The vessels were fixed and prepared as described in Methods, embedded in paraffin, and stained for elastin. Sections of proximal descending aorta were subjected to morphometric analysis of intimal area and medial area using an automated videomicroscopy system.
Values are displayed as mean±SEM and represent analysis of six sections per animal taken from six animals in each group. Aortic cholesterol and phospholipid levels were determined as described in Methods and represent data taken from 6-10 animals in each group. * P < 0.05 vs control. The preservation of EDRF action in cholesterol-fed rabbits by probucol has been reported previously by Simon and colleagues (22) . These investigators found that dietary probucol preserved endothelium-dependent arterial relaxation in rabbits fed a 0.5% (wt/wt) cholesterol diet for 10 wk. In addition, Simon and coworkers found that probucol had no effect on endothelium-dependent arterial relaxation in normal rabbits, ruling out the possibility that probucol treatment results in a nonspecific enhancement of EDRF action. These authors also suggested that the effect of probucol was related to its antioxidant activity as manifested by a reduction in the plasma content of TBARS. In contrast to the present study, Simon Probucol is extremely effective in preventing both copperand cell-mediated LDL oxidation (21) . Normal rabbit arteries exposed to ox-LDL develop impaired endothelium-dependent arterial relaxation (12) and ox-LDL has been shown to inactivate EDRF directly (15) . Thus, one possible mechanism for the beneficial effect of probucol on endothelial function in this study is the reduced formation of ox-LDL in the vascular wall. This contention is supported by our observations that LDL derived from probucol-treated animals demonstrated enhanced resistance to ex vivo copper-induced oxidation and this effect correlated with receptor-mediated EDRF action. Moreover, probucol treatment of cholesterol-fed animals was associated with a significant reduction in the TBARS content of thoracic aorta that also correlated with preserved EDRF action. Since LDL oxidation is associated with the formation of TBARS within the particle (55) and clinically relevant LDL oxidation occurs in the vessel wall (56) , these data are consistent with reduced ox-LDL formation in vivo. It is important to interpret these findings with some caution, however, as the measurement of TBARS in biologic samples is not specific for the formation of ox-LDL (57) .
The oxidation of LDL involves lipid peroxidation and the conversion of PC to lysoPC within the LDL particle (54) . We found increased levels of lysoPC in the thoracic aorta of cholesterol-fed animals, whereas animals fed both cholesterol and probucol had normal arterial lysoPC content (Table IV) . Similarly, the ratio of PC to lysoPC, an index of phospholipid oxidation, was significantly reduced in cholesterol-fed animals compared to animals that consumed both probucol and cholesterol. Taken together, these findings also support the hypothesis that probucol prevents the formation of ox-LDL in the arterial wall of cholesterol-fed rabbits.
The accumulation of lysoPC in the arterial wall has potential implications for endothelium-dependent arterial relaxation. The transfer of lysoPC from ox-LDL to endothelial cells has been demonstrated in vitro (12) and results in abnormal receptormediated EDRF action through the inhibition of membraneassociated inhibitory G proteins (58) . Our findings are consistent with these effects of lysoPC on EDRF action. We found that animals fed 0.5 or 1% cholesterol developed abnormal endothelium-dependent arterial relaxation to acetylcholine, a Gi protein-dependent EDRF agonist, in association with the arterial accumulation of lysoPC and a reduction in the ratio of arterial PC to lysoPC. Relaxation responses to A23187, a receptor-independent EDRF agonist, were less sensitive to these changes and this is consistent with previous reports (for review see reference 58). In contrast, probucol-treated animals had normal levels of lysoPC in the thoracic aorta and normal responses to both acetylcholine and A23 187. Thus, our data indicate that in cholesterol-fed rabbits, probucol protects LDL against oxidation in vivo with a concomitant reduction in vascular oxidative stress and, as a consequence, prevents the accumulation of lysoPC in arterial tissue.
Recent studies have demonstrated that lysoPC stimulates net smooth muscle cell production of superoxide in rabbit aorta through a protein kinase C-mediated mechanism (34) . In this study, we found that animals consuming cholesterol demonstrated a dose-dependent increase in vascular superoxide generation, whereas probucol-treated animals did not demonstrate such changes (Fig. 4) . More importantly, we found that both the aortic content of lysoPC and the ratio of PC to lysoPC correlated strongly with vascular superoxide generation ( 5). One possible interpretation of these data is that probucol prevented increased vascular superoxide generation in cholesterol-fed rabbits through a reduction in the tissue content of lysoPC. Consistent with this interpretation, we found enhanced antioxidant protection of LDL in probucol-treated animals (Table II). We would submit that incorporation of probucol into LDL limits LDL oxidation in the vascular wall and, as a consequence, limits the local formation of lysoPC resulting in a diminished stimulus for protein kinase C-mediated superoxide generation (34) .
The prevention of LDL oxidation by probucol is generally attributed to its incorporation into the LDL particle (59). We report here an effect of probucol on vascular superoxide generation that provides an additional mechanism for reduced LDL oxidation with probucol treatment. Current evidence suggests that cell-mediated LDL oxidation is facilitated by superoxide (41) (42) (43) , possibly via the reduction of redox-active iron (60) that is available in the vascular wall (61) . Therefore, any reduction in superoxide formation resulting from probucol treatment would also limit the formation of ferrous iron in the vascular wall and thus, limit the oxidation of LDL.
We observed an increase in vascular superoxide generation from the thoracic aorta of cholesterol-fed rabbits that was associated with impaired endothelium-dependent arterial relaxation ( Fig.  1 A and Fig. 4 ). Since EDRF is readily inactivated by superoxide ( 16), it is attractive to speculate that probucol treatment preserved EDRF action, in part, by limiting vascular superoxide generation and thus, preventing direct inactivation of EDRF. There is considerable evidence indicating that reducing the availability of superoxide in hypercholesterolemia and atherosclerosis is beneficial for EDRF action. Cholesterol-fed rabbits chronically treated with polyethylene glycol-conjugated SOD demonstrate enhanced tissue SOD activity and improved endothelium-dependent arterial relaxation (19) . Likewise, dysfunctional arteries derived from atherosclerotic rabbits demonstrate improved endothelium-dependent relaxation and increased intracellular SOD activity after treatment with liposome-encapsulated SOD (20) .
The availability of superoxide in vascular tissues is related to the relative rates of superoxide generation and inactivation. Our data would indicate that dietary probucol truly limits the generation of superoxide from cholesterol-fed rabbit thoracic aorta. We found no difference in CuZnSOD activity, or residual water-and lipid-soluble superoxide scavenging activity of thoracic aorta on the basis of dietary treatment. Furthermore, we specifically assessed vascular superoxide generation in the presence of DDC, an inhibitor of CuZnSOD (33) , to estimate the total generation of superoxide. The particular importance of total vascular superoxide generation is readily apparent from kinetic data on the interaction of superoxide with NO. Superoxide and NO react with a diffusion-limited rate constant of -6.7 x 109 M'-/s'- (62) that is fourfold greater than the rate constant for SOD-mediated superoxide dismutation (63) Figure 6 . Proposed scheme for the effect of probucol on EDRF action and metabolism in cholesterol-fed rabbits. LDL is incorporated into the arterial wall where it is subject to cell-mediated oxidation. The oxidation of LDL is associated with the conversion of PC to lysoPC resulting in the activation of protein kinase C in endothelial and smooth muscle cells resulting in: (a) inhibition of receptor-mediated EDRF action and (b) enhanced net superoxide production. Superoxide is then available for direct inactivation of EDRF as well as promotion of LDL oxidation through the reduction of ferric iron. Potential sites for probucol action include: (A) the inhibition of LDL oxidation via probucol incorporation into LDL and, perhaps (B) prevention of superoxide production via a direct cellular effect. There is no evidence for direct superoxide scavenging by probucol.
cholesterol levels alone would explain the results reported here. Similarly, tissue cholesterol levels do not completely explain the effect of probucol on superoxide generation because probucol treatment did not reduce tissue cholesterol to control values (Table IV) , while it did reduce vascular superoxide generation to control levels. Probucol also did not significantly reduce intimal proliferation suggesting that this parameter was not responsible for the observed effect of probucol on vascular superoxide generation. There is one report indicating that probucol scavenges superoxide anion in vitro (47) . One must consider, therefore, that the effect of probucol on vascular superoxide generation is a consequence of direct superoxide scavenging in vascular tissue. We consider this possibility unlikely for two reasons. First, we were unable to detect any superoxide scavenging activity with probucol using xanthine/xanthine oxidase and superoxide detection with lucigenin chemiluminescence, or cytochrome c reduction (data not shown). Second, using the most favorable assay for detecting superoxide scavenging activity with probucol (i.e., photooxidation of dianisidine), we were also unable to detect a significant increase inlipid-soluble superoxide scavenging activity in probucol-treated animals (Table IH) .
We would propose the following scheme for the effects of probucol observed in this study (Fig. 6) . In cholesterol-fed animals, LDL accumulates in the subendothelial space of the vascular wall and is subject to oxidation by resident vascular cells (9) (10) (11) leading to direct inactivation of EDRF (15) , the conversion of PC tolysoPC (54) , and TBARS formation (54) . The local accumulation oflysoPC produces smooth muscle cell (34) and endothelial cell (64) protein kinase C activation, resulting in the increased availability of superoxide in smooth muscle cells (34) and a reduction in receptor-mediated EDRF release from endothelial cells (64). The increased availability of superoxide has the dual effect of inactivating superoxide directly and enhancing LDL oxidation through the reduction of iron (60) that is available in the vascular wall (61) . Our data support a role for the inhibition of LDL oxidation by LDL probucol (Fig. 6, A) preventing the cascade of events outlined above. Additionally, a direct effect of probucol on vascular superoxide generation (Fig. 6, B ) cannot be excluded as this would also explain the reduction in tissue TBARS and lysoPC content reported here. Presently, we have no direct evidence for such an effect although direct effects of probucol on vascular cells have been described (65, 66) . There is no evidence for direct scavenging of superoxide by probucol in vascular tissue.
In summary, the data presented here indicate that antioxidant treatment with probucol effectively improves EDRF action in cholesterol-fed rabbits. Moreover, the preservation of EDRF action is directly related to the antioxidant activity of probucol as manifested by a reduction in the vascular content of TBARS and lysoPC, as well as a reduction in the vascular generation of superoxide. These data provide evidence that the disturbances of vasomotor function associated with hypercholesterolemia result, in part, from an imbalance between vascular oxidative stress and antioxidant protection. In addition, these data are consistent with the hypothesis that antioxidants may benefit patients with hypercholesterolemia and atherosclerosis by reducing vascular oxidative stress and thus, improving EDRF action.
